Physician profile
Daniel Williams
NPI 1699984641
$213,320.20
in general payments reported to CMS, 2019-2025
6 companies · $76K in 2025
The $76K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $7,533 · 2021: $18K · 2022: $27K · 2023: $34K · 2024: $50K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $142K · Consulting Fee: $11K · Travel and Lodging: $5,466 · Food and Beverage: $1,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $141,956.00 |
| Consulting Fee | $11,017.96 |
| Travel and Lodging | $5,466.25 |
| Food and Beverage | $1,690.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart Sa | $181,141.00 | 2020-2025 | Perla Tl - Deformity Screw, Juliet Ll - Lateral Plate Ti-Life |
| Spineart USA INC | $30,506.69 | 2020-2025 | Juliet Ll |
| Crossroads Orthopedics, LLC | $1,409.14 | 2021-2023 | |
| Linvatec Corporation | $163.14 | 2024 | Biobrace 23mm |
| Ferring Pharmaceuticals INC. | $72.06 | 2019 | |
| Zimmer Biomet Holdings, INC. | $28.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.